May. 14, 2026[EVENT]
Join Our Upcoming Webinar: Introduction to EpiSensA
July 16, 2026
Featuring a Keynote Presentation by Sho Suzuki (Kao Corporation)
We are pleased to invite you to an introductory webinar on EpiSensA, a reconstructed human epidermis (RhE)–based method for skin sensitization testing.
This session will provide a clear and concise overview of EpiSensA, covering both its technical foundations and practical applications. It is ideal for researchers and professionals interested in RhE-based approaches for in vitro safety assessment.
A key highlight of the webinar is a keynote presentation by Sho Suzuki (Kao Corporation), who will share valuable scientific insights and real-world perspectives on skin sensitization evaluation.
Take your first step into EpiSensA: Register Now
| Date & Time | Thursday, July 16, 2026 4:00 PM (CEST) | 10:00 AM (EDT) |
|---|---|
| Format | Live Online (Zoom Webinar) |
| Speakers & Topics |
Keynote Presentation Opening Presentation |
EpiSensA is an OECD Test Guideline–listed method (TG 442D) that utilizes the LabCyte EPI-MODEL24, a reconstructed human epidermis (RhE) model developed by culturing human-derived epidermal cells in vitro.
Learn more about LabCyte
(Reconstructed Human Tissue Models)